APP and Alzheimer disease: Given the anti-amyloidogenic activity of CD74, it is possible that the increased levels of CD74 in AD brains, potentially caused by increased TNFα in AD patients and in transgenic mouse over expressing APP [41-43], could contribute to a negative feedback mechanism of the organism to fend off noxious APP processing up regulation.